AwardApr 30, 2026, 03:02 PM
ABBV Awards RIME Therapeutics Biotech Innovators Award
AI Summary
AbbVie, in partnership with adMare BioInnovations, recognized RIME Therapeutics as the recipient of the AbbVie Biotech Innovators Award. This award aims to foster innovation and support growth in Quebec’s life sciences sector. RIME Therapeutics, founded in 2025, is a Montreal-based startup developing a peptide-based drug discovery platform for inflammation and immunology. The award provides RIME with one year of laboratory and office space at the adMare Innovation Centre, access to shared equipment, and mentorship from AbbVie's scientific and business leaders.
Key Highlights
- AbbVie and adMare BioInnovations awarded RIME Therapeutics the AbbVie Biotech Innovators Award.
- RIME Therapeutics is a Montreal-based startup focused on peptide-based drug discovery for inflammation and immunology.
- The award provides RIME with one year of laboratory and office space at the adMare Innovation Centre in Montreal.
- RIME will also receive access to shared equipment and services.
- Mentorship from AbbVie's scientific and business leaders will be provided to RIME Therapeutics.
- The award supports early-stage biotech companies aligned with AbbVie's therapeutic areas.
Price Impact
More from ABBV